LARS1 and melanoma: Given that interactions between aberrant glycans on tumor cells and CLRs on DCs could potentially contribute to immune subversion, we first investigated the impact of different primary tumor cell lines derived from melanoma patients on cytokine production by DC subsets upon TLR stimulation.